Thanks;ARIZONA CENTER for ADVANCED MEDICINE
Autohemotherapy is a technique used all over the world to boost the immune system. The technique is very simple. A small amount of blood is withdrawn from a vein, and re-introduced into a muscle by injection.
Autohemotherapy is a technique used all over the world to boost the immune system.
autohematherapyThe technique is very simple. A small amount of blood is withdrawn from a vein, and re-introduced into a muscle by injection. This creates a tiny inflammatory response which acts very much like a wound. Muscle is slightly injured by the injection, since the needle used (no matter how small the gauge) is larger than capillaries. Injured capillaries leak calls platelets into the tissues, thus triggering the release of growth factors and inflammatory proteins. The immune system is now activated. If there are foreign proteins in the blood, these proteins are picked up by antigen presenting cells and given to the T cells of the immune system to make the appropriate antibodies.
And voilà – effectively we have created a vaccine. If the proteins belong to cancer cells, we have created an effective vaccine against cancer. And because we repeat the autohemotherapy frequently, every injection contains fresh proteins. We are not risking making a vaccine to something which is no longer relevant – the major drawback of conventional cancer vaccines.
The International Journal of Artificial Organs [2004, 27(9):766-771]
Type: Clinical Trial, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov’t
Ozonotherapy is a complementary medical approach in the treatment of resistant infections, immune deficiency syndromes, orthopedic pathologies and vascular diseases. The criticism of this method is associated with potentially harmful effects of ozone on cells. The aim of this study was to investigate the influence of ozonated autohemotherapy (O3-AHT) on the cellular response of the immunologic system represented by cytotoxic activity of natural killer cells. 12 hemodialyzed patients (8 M, 4 F) aged 64.8 +/- 7.6 years with peripheral arterial disease as the main reason for the treatment with O3-AHT were examined in a prospective, placebo controlled, single blind study. They received 9 sessions of autohemotherapy without ozone exposure as a placebo-control and subsequent 9 sessions of O3-AHT. The procedures were performed 3 times a week, just before hemodialysis session. Ozone-oxygen gas mixture with ozone concentration of 50 microg/ml produced by ozone generator (ATO3, KrioMetrum, Poland) was used during O3-AHT Natural killer cell activity was measured using lactate dehydrogenase release assay There was no statistical difference between natural killer cell activity (%) at the baseline (16.78 +/- 8.07), after nine sessions of control autohemotherapy (15.98 +/- 6.67), and after nine sessions of O3-AHT (18.26 +/- 8.82). In conclusion, our findings showed that O3-AHT in a dose of 50 mg/mL does not have any significant influence on natural killer cell function in hemodialyzed patients.